Request Demo
Recent blog posts
Latest Hotspot
8 min read
NCT07451795 Retlirafusp alfa Metastatic castration-resistant prostate cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07451795 clinical trial report covering Retlirafusp alfa, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07452250 Ferumoxytol Vein disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07452250 clinical trial report covering Ferumoxytol, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07450859 Nuzefatide pevedotin Metastatic Pancreatic Ductal Adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07450859 clinical trial report covering Nuzefatide pevedotin, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07450976 SHR-A1904 Biliary Tract Neoplasms Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07450976 clinical trial report covering SHR-A1904, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07451652 Gemcitabine Hydrochloride Diffuse large B-cell lymphoma recurrent Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07451652 clinical trial report covering Gemcitabine Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07453069 FB-301 Vaginal flora imbalance Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07453069 clinical trial report covering FB-301, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07451886 Fludrocortisone Acetate Shock, Septic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07451886 clinical trial report covering Fludrocortisone Acetate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07453004 Plonmarlimab Primary gout Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07453004 clinical trial report covering Plonmarlimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07451171 Sulfamethoxazole/Trimethoprim Malnutrition Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07451171 clinical trial report covering Sulfamethoxazole/Trimethoprim, Phase 2, endpoints, sponsor, geography, readout timing and development white spac
Latest Hotspot
8 min read
CTR20260647 68Ga-HX01 Soft Tissue Sarcoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
CTR20260647 clinical trial report covering 68Ga-HX01, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07455019 Pembrolizumab Esophageal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07455019 clinical trial report covering Pembrolizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07455604 Silver Diammine Fluoride Dental Caries Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07455604 clinical trial report covering Silver Diammine Fluoride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.